| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.035 |
0.9 |
| mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.019 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
NU-7441 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
0.0048 |
0.9 |